How many patents does
Bristol-Myers Squibb Company have?
patents
15,996
families
1,745
granted
4,163
applications
11,833
US
3,223
EP
2,065
WO
1,098
CN
1,071
JP
671
KR
447
GB
1
RoW
7,420
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Bristol-Myers Squibb Company
Top ten assignees appearing on patents
2009 - 2018
| bristol-myers squibb company | 11490 |
| convatec technologies | 427 |
| medarex | 380 |
| pfizer | 247 |
| zymogenetics | 216 |
| bristol-myers squibb holdings irel… 🛈 | 180 |
| astrazeneca | 149 |
| viiv healthcare uk (no.5) | 133 |
| alderbio holdings | 118 |
| mead johnson nutrition company | 118 |
Bristol-Myers Squibb Company
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| antibodies to il-6 and use thereof | 107 | 2008 |
| hepatitis c virus inhibitors | 86 | 2006 |
| modulators of chemokine receptor activity, crystalline forms and process | 75 | 2006 |
| crystalline solvates and complexes of (1s)-1,5-anhydro-1-c-(3-((phenyl)methyl)phenyl)-d-… 🛈 | 73 | 2006 |
| human monoclonal antibodies to programmed death 1(pd-1) and methods for treating cancer … 🛈 | 71 | 2005 |
| binding molecules to the human ox40 receptor | 70 | 2007 |
| pyridone gpr119 g protein-coupled receptor agonists | 66 | 2007 |
| stable protein formulations | 66 | 2005 |
| lactam-containing compounds and derivatives thereof as factor xa inhibitors | 64 | 2001 |
| dihydropyridone p1 as factor xia inhibitors | 64 | 2012 |